Dr. Kevin R. Murphy, MD

Dr. Murphy practices at Boys Town National Research Hospital - Downtown in Omaha, Nebraska.

Dr. Murphy's NPI, 1326181249, was assigned on February 14, 2007. Dr. Murphy graduated from UNMC in 1979. Dr. Murphy holds Nebraska license 16946.

Dr. Murphy's primary practice is Boys Town National Research Hospital - Downtown, at 555 N 30th St, Omaha, NE 68131 in Douglas County. The practice phone is (402) 498-6509.

Dr. Murphy's primary practice is Boys Town National Research Hospital - Downtown in Omaha, Nebraska. Dr. Murphy is also affiliated with Boys Town National Research Hospital. The medical group on file is Boys Town National Research Hospital. Dmand AI also links Dr. Murphy to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murphy practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Murphy's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Murphy is board certified in pediatric pulmonology by the American Board of Pediatrics. Dmand AI has Dr. Murphy's licenses on file in 3 states: Nebraska, Colorado and Iowa.

Dmand AI lists asthma, chronic nasal allergies and hives among the conditions Dr. Murphy treats.

CMS data shows 267 Medicare services from Dr. Murphy across 5 procedure codes in 2024, for 49 Medicare patients. Medicare paid $7,852 for them. Every service was in an office.

CMS counts 49 Medicare patients who saw Dr. Murphy in 2024. The largest group is 65 to 74, with 28 patients. 73% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Murphy's median patient age at 17, with 53% women.

In 2024, Dr. Murphy wrote 468 Medicare Part D claims for 56 patients. 56% of them were for generic drugs. CMS names the drug for 366 of them, across 13 drugs with 11 or more claims each, at $138,620 in total drug cost. In 2023, CMS named 281 claims across 9 drugs.

Dr. Murphy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 104 papers to Dr. Murphy, published from 2005 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Asthma, Anti-Asthmatic Agents and Attention Deficit Disorder with Hyperactivity. Dr. Murphy has published most often in Ann Allergy Asthma Immunol. Dr. Murphy's most frequent co-authors are Bradley Elliott Chipps, MD, Ileen A. Gilbert, MD and David A. Beuther, MD.

Dmand AI links Dr. Murphy to 3 clinical trials. Conditions studied include Asthma, Respiratory Hypersensitivity and Angioedema. Sanofi sponsors the most, 2. Open Payments lists research payments to Dr. Murphy that name 3 trials.

CMS Open Payments shows 1,533 general payments to Dr. Murphy from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. AstraZeneca Pharmaceuticals LP paid the most, $947,855. It also lists 21 research payments totaling $32,880 from 2017 to 2023, naming 3 clinical trials.

Dmand AI lists 1 award for Dr. Murphy.

Dr. Murphy graduated from UNMC in 1979. Dr. Murphy is a member of AAP.

Dr. Murphy is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.